SPACs and Blank-Check Companies

A SPAC starts as a public shell

A special purpose acquisition company, or SPAC, is a company formed to raise money through a public offering and later combine with an operating business. At its initial public offering, the SPAC is typically a shell rather than a company with an established operating business. Its public investors are initially relying on the sponsor and management to identify and complete a transaction. The later merger or acquisition is commonly called a de-SPAC transaction. After completion, the combined public company generally carries on the target’s business.

This sequence differs from a traditional operating-company IPO. In a traditional IPO, the business itself sells shares to the public and investors assess its existing operations, financial statements, strategy, and risks. A SPAC investor at the shell stage is evaluating the sponsor, deal terms, trust arrangements, and the possibility of a future target. The target may not yet be known. Even if the prospectus identifies an intended industry, the SPAC is not necessarily obligated to choose a target in that industry.

The trust account and redemption decision

SPAC IPO proceeds, after certain permitted uses, are typically held in a trust or escrow account until a business combination or liquidation. The account terms determine what happens to the funds and what investors can receive. At the de-SPAC stage, shareholders commonly have an opportunity to redeem their shares for a pro rata portion of the trust balance instead of remaining invested in the combined company. If no transaction is completed and the SPAC liquidates, public shareholders generally have rights to their pro rata trust amount under the governing documents.

The trust value is not necessarily the market price paid by a later purchaser. Suppose the trust has approximately $10 for each public share, but an investor buys the share on an exchange for $12 because the market expects an attractive target. If that investor later redeems for roughly the pro rata trust amount, the starting market premium is not automatically returned. The SEC’s illustrative bulletin makes this point with a $10 IPO unit and a $12 open-market purchase. Actual amount and eligibility depend on the security, account terms, taxes, timing, and transaction documents.

The redemption right also does not make the SPAC risk-free. The investor may lose the premium paid above the trust amount, and the value of warrants or other components may move separately. In a proposed business combination, investors must follow the documents’ redemption process and deadlines. The decision is often between receiving the defined trust amount and accepting the risks and prospects of the combined operating company; it is not simply a choice between a guaranteed original purchase price and a new stock.

Units, shares, and warrants are different securities

SPAC IPOs often sell units consisting of common stock and a warrant or a fraction of a warrant. A warrant gives its holder a contractual right, subject to its terms, to buy a stated number of shares at a stated price during a stated period. A unit is not necessarily identical to a share. After the IPO, the components may begin trading separately, with different symbols. Before placing an order, determine whether it is for a unit, common share, or warrant.

Warrant terms vary. The document specifies the number of shares purchasable, exercise price, expiration, and whether the company can redeem the warrant under stated conditions. If an investor ignores a redemption notice and fails to exercise within the stated period, a warrant may lose value or expire worthless. A warrant is not a right to redeem for the trust account. It is a separate contract, and its value depends on its own terms and the share price.

For example, imagine one unit contains one common share and one-half warrant, and each whole warrant permits purchase of one share for $11 before a specified expiration date. Two units would represent two common shares and one whole warrant. They would not mean the investor owns three shares immediately. If the warrant later becomes exercisable, the investor must pay the exercise price and follow the contract. This simple decomposition prevents the common mistake of treating every unit as an equivalent amount of ordinary stock.

Sponsor incentives and dilution

SPAC sponsors may receive an equity interest on terms different from those available to public shareholders, and a transaction may involve additional financing. Those features can create conflicts: a sponsor may have an incentive to complete a deal even when public shareholders would prefer liquidation or redemption. The relevant question is not whether every sponsor acts improperly; it is how sponsor compensation, ownership, financing, and deadlines affect the incentives in this particular SPAC.

Suppose a SPAC has 10 million public shares supported by $100 million in trust, while sponsor and other securities add potential shares if the transaction closes. If those securities convert or are issued, the combined company may have more shares outstanding than a simple trust-per-share figure suggests. A target valued at $500 million does not automatically translate into $50 per share by dividing by the original public float; the capital structure, sponsor shares, warrants, additional financing, redemptions, and target owners’ consideration all matter. Read the transaction’s pro forma capitalization and dilution disclosures.

A financing sponsor may contribute cash in exchange for a loan or a security with different rights. That can preserve transaction cash while creating another claim or dilution path. Review the deal materials for the sponsor’s interests, related-party agreements, and any payments associated with the combination. The SEC bulletin identifies these as important points in the IPO prospectus and de-SPAC disclosure. The particular structure matters more than a general label such as “SPAC deal.”

The business combination is a fresh investment decision

When a target is announced, evaluate the operating company rather than assuming the SPAC’s earlier terms settle the question. Read the proxy statement/prospectus, information statement/prospectus, or tender offer statement that applies. These materials describe the target’s business and financial statements, transaction terms, parties’ interests, financing, share rights, and redemption or voting procedures. A shareholder vote may be required in many transactions, but rights and process can depend on structure; inspect the actual documents.

A useful review starts with the target’s revenue sources, customer concentration, margins, cash needs, debt, and competitive position. Then consider the valuation implied by the transaction, including shares issued to target owners and any financing. Compare the stated enterprise value with realistic operating assumptions, and account for dilution from warrants and sponsor securities. Forecasts included in transaction materials may be optimistic; ask what happens if growth is slower, the company needs more capital, or redemptions reduce cash available at closing.

The same public share can represent different choices at different stages. Before a target is found, the investor’s thesis may center on sponsor quality and the trust arrangement. After a proposed combination, the thesis must include the target, transaction price, financing, governance, and dilution. Holding through the transaction is not a passive continuation of the original shell investment; it is an affirmative exposure to a new operating business.

A worked decision with trust value and premium

Assume a public SPAC share has a trust value of $10.20 per share before a proposed transaction. An investor purchased it on the market at $11.40. If the investor chooses redemption and the documents permit payment of $10.20, the difference is a $1.20 loss per share before considering any tax, fees, trust interest, or market movement. For 500 shares, the gross purchase cost was $5,700 and the illustrative trust amount is $5,100, a $600 gap. The investor should not use the original $11.40 purchase price as the expected redemption amount.

Suppose the combined company’s forecast appears attractive, but the deal includes 20 million sponsor shares, 15 million shares for target owners, 10 million public shares remaining after redemptions, and warrants that could add more shares. The investor should calculate ownership on a fully diluted basis when the relevant securities are included, and examine whether the company’s valuation remains supportable. Redemption may avoid exposure to the target but sacrifices participation if the transaction later succeeds. Staying invested preserves exposure and accepts business and capital-structure risk. The right answer depends on the investor’s analysis and objectives, not on a rule that all SPACs should be redeemed or held.

Questions to ask before trading

Identify the exact instrument and its terms. Does the ticker represent a unit, share, or warrant? What is held in trust, and what can reduce it? What deadline applies to a transaction or liquidation? Can the investor redeem, and what steps are required? What happens to each warrant after a merger? How much dilution may result from sponsor interests, target consideration, warrants, or new financing? These questions can be answered only by combining the prospectus with current reports and transaction documents.

A SPAC can provide a route for a private operating company to become public, but the structure has separate shell and operating-company phases. The trust may provide a defined redemption mechanism, yet it does not guarantee that every purchase price will be recovered. Sponsor incentives and potential dilution can alter the economics. Treat the initial IPO, the announced deal, and the post-merger company as connected but distinct analytical stages.

Timing and liquidation terms are part of the risk

A SPAC prospectus generally specifies a period in which the sponsor expects to complete a business combination, and the governing documents may allow an extension. The time period and extension process are deal-specific. A shorter deadline can increase pressure to transact; an extension may require a shareholder vote or other procedure. If no transaction occurs, liquidation typically returns a pro rata trust amount to eligible public shareholders, but the exact amount and treatment of warrants, taxes, and expenses depend on the documents. Review the permitted deductions and dates rather than treating the trust as a fixed insured deposit.

A vote and a redemption are also separate questions. In many deals, public holders can vote on the proposed combination and redeem their shares, but the exact voting and redemption mechanics vary. Some structures may proceed without a public shareholder vote while still providing an alternative disclosure or tender process. The transaction documents explain the rights available and the steps to exercise them. Missing a deadline can change the investor’s options even when the investor has a strong opinion about the target.

These details make a SPAC position operationally different from an ordinary common share. The holder should monitor current reports, proxy materials, tender offer materials, and notices about unit separation or warrant redemption. A brokerage account may not deliver every contractual notice in a way the investor expects. The SEC recommends consulting the SPAC’s filings and monitoring warrant information. This is practical diligence: a sound view of the target does not preserve an expired warrant or missed redemption window.

Do not confuse a warrant’s trading symbol with a redemption right attached to common stock. A holder who redeems common shares may receive the trust amount under the applicable terms, while a warrant holder exercises or sells the warrant under its contract. If a unit has separated, owning one component does not imply ownership of another. Reconstruct the investor’s actual position from the brokerage confirmation and the security description before estimating either redemption proceeds or future dilution.